Healthtech Startups

The Gleamery is a dental boutique offering hygienist-led teeth cleanings, whitening, night guards, cavity prevention/repair, and FDA-cleared GleamFit overnight clear aligners in a spa-style studio setting. It serves consumers seeking convenient, comfort-focused dental care, with locations in Los Angeles.

2 investors

The Good Patch makes wearable patches designed to support wellness and beauty, including sleep improvement and stress relief. The patches use plant-based ingredients and are marketed as alternatives for consumers seeking convenient wellness solutions.

2 investors

The Lanby curates and recommends wellness products from third-party brands across categories including supplements, fitness equipment, kitchen items, and home goods aligned with holistic health principles. The company serves consumers seeking quality wellness essentials and personalized long-term health partnerships.

2 investors

The Lowdown is a women's health platform where women review contraception, medicines and conditions such as PCOS and endometriosis to help others make informed health decisions. It also offers medically approved decision-making tools and clinician consultations focused on hormonal health and weight gain.

2 investors

The Patient Company develops SimPull, a mechanical patient handling and transfer device designed to reduce injury risk for caregivers and patients in clinical settings. The product targets hospitals and healthcare facilities seeking safer, more efficient lateral patient transfer methods.

2 investors

The Stepping Stones Group delivers therapeutic and behavioral health services to children with special needs and autism. The organization partners with mission-driven entities to improve service quality and community impact nationwide.

2 investors

Eva is an AI-powered research platform that conducts and maintains systematic reviews and meta-analyses by continuously updating them as new clinical trials emerge. It deploys AI research assistants to work alongside human expert reviewers to deliver initial analyses within 48 hours and keep findings current.

2 investors

Theraclion develops ultrasound-based medical devices for non-invasive treatment of vascular and thyroid conditions. The company designs robotic platforms combining ultrasound imaging and robotics for patients seeking alternatives to surgery.

2 investors

Theranica develops non-invasive, drug-free wearable therapeutic devices for pain treatment, combining neuroscience research with mobile digital technology. Its products target patients seeking personalized pain therapeutics.

2 investors

Therapydia provides physical therapy services with individualized treatment plans tailored to each patient's needs and recovery goals. It offers direct patient appointments without requiring a referral.

2 investors

TTP develops the Thermo Trauma Port, a novel patient transfer device for the trauma care pathway, created with a consortium including East Anglian Air Ambulance, University Hospital of Birmingham and the University of Portsmouth. The device targets pre-hospital and in-hospital emergency and critical care settings, with clinical usability testing conducted through the NIHR.

2 investors

Theromics develops protein-based injectable nanogel accelerants (HeatSYNC and CryoSYNC) that improve energy transfer in soft tissue to make thermal ablation procedures larger, more spherical, and more effective, and to combine ablation with localized drug or immunotherapy delivery. It targets interventional oncology and conditions such as uterine fibroids, endometriosis, and breast cancer, and was spun out of Brown University.

2 investors

Therorna develops circular RNA-based therapeutic candidates and preventive medicines for diseases with unmet clinical needs. The company was founded in 2021 by domestic experts and overseas-educated PhDs to advance circular RNA technology in drug discovery and therapy.

2 investors

Thesis Care provides clinical support services to healthcare organizations using technology to enable high-value work at scale, helping improve patient outcomes and experience.

2 investors

Theta Neurotech develops a non-invasive wearable EEG patch combined with an AI-powered mobile application designed to predict seizures. The system serves individuals with epilepsy and related neurological conditions.

2 investors

Thetis is a clinical-stage pharmaceutical company developing TP-317, an oral Resolvin E1 drug that activates the BLT1 receptor to restore tissue and immune balance. It is being developed for inflammatory bowel disease, including ulcerative colitis, and solid tumors.

2 investors

Think Research works with health systems to improve care delivery through clinical software, clinical expertise, and hands-on operational support across access to care, clinical workflow, and medication safety. It serves hospitals, care sites, and clinicians, offering vendor-agnostic tools that integrate with existing EHR/EMR systems.

2 investors

Third Pole develops portable and miniaturized devices that generate inhaled nitric oxide on-demand for hospital and mobile treatment of severe cardiopulmonary diseases and lung infections. The company uses a patented technology inspired by natural lightning to produce nitric oxide safely and efficiently from air and electricity.

2 investors

Celerion provides clinical pharmacology and bioanalytical services to support pharmaceutical and biotechnology companies in early-phase drug development and regulatory submissions. The company operates clinical research units and bioanalytical laboratories across North America and Europe.

2 investors

Thrive is a company whose leadership actively collaborates with the American Heart Association to advance cardiovascular health research, prevention, and education. The company engages employees, clients, and its industry network in fundraising and awareness initiatives supporting heart disease prevention globally.

2 investors

Thrive Mobile provides affordable wireless plans through the Lifeline program, powered by SafetyNet Wireless, with plans starting at $0/month and integrated health resources for low-income users. The service includes access to a mobile app and Thrive Assistants support for scheduling and connection to local resources.

2 investors

Thrombolex develops endovascular catheters using pharmaco-mechanical technology to treat arterial and venous thromboembolic (A+VTE) conditions by dissolving blood clots. Its FDA-cleared products are based on the BASHIR Endovascular Catheter platform for medical practitioners treating vascular disease.

2 investors

Thryve provides a platform that enables partners to improve patient engagement, preventive care, and clinical research through real-world health insights and insurance innovation.

2 investors

Thynk Health provides patient management software focused on closing the loop on cancer screening and incidental findings, automating follow-up so patients do not fall through the cracks. It serves health systems and oncology care programs, and has become part of Azra AI.

2 investors